Expanding DMD Treatment Horizons New Evidence

This activity is designed to equip clinicians with the knowledge and skills needed to optimize care for patients with Duchenne muscular dystrophy (DMD) across the age spectrum. Through expert-led sessions, participants will enhance their ability to determine therapeutic candidacy, perform appropriate clinical assessments, and apply the latest evidence from clinical studies to inform treatment decisions. The series also addresses strategies for ongoing monitoring and managing age-specific considerations in patients receiving DMD therapies.

COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an independent medical educational grant from Sarepta.

CME/CE INFORMATION
https://www.francefoundation.com/9398...

CLAIM CREDIT
https://surveys.francefoundation.com/...